Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
Hoffmann-La Roche
Sumanta Kumar Pal; Laurence Albiges; Piotr Tomczak; Cristina Suárez; Martin H Voss; Guillermo de Velasco; Jad Chahoud; Anastasia Mochalova; Giuseppe Procopio; Hakim Mahammedi; Friedemann Zengerling; Chan Kim; Takahiro Osawa; Martín Angel; Suyasha Gupta; Omara Khan; Guillaume Bergthold; Bo Liu; Melania Kalaitzidou; Mahrukh Huseni; Christian Scheffold; Thomas Powles; Toni K Choueiri